AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Designed fabrication of active tumor targeting covalent organic framework nanotherapeutics via a simple post-synthetic strategy

Yue Yu1,2( ), Guoxin Zhang3, Zhongping Li4,5( ), Jia Wang2, Yang Liu6, Rahul Bhardwaj4, Renu Wadhwa2, Yuki Nagao4, Mototada Shichiri1,2, Ran Gao3( )
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Osaka 563-8577, Japan
AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), AIST, Tsukuba, Ibaraki 305-8565, Japan
Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, NHC Key Laboratory of Human Disease Comparative Medicine, National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage, Beijing 100021, China
School of Materials Science, Japan Advanced Institute of Science and Technology, Ishikawa 923-1211, Japan
Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
Flexible 3D System Integration Laboratory, SANKEN, Osaka University, Osaka 567-0047, Japan
Show Author Information

Graphical Abstract

A highly cancer targeting covalent organic framework (COF), that shows low toxicity, well-dispersibility, and high drug loading capacity, is reported. Comparing to drug administrated alone, the folate-functionalized COF nanocarrier significantly enhances the selectivity and cytotoxicity of its loaded drug, resulting in nearly 7-fold decrease in final tumor volume. Such exceptional antitumor activity indicates great potentials of COF-based nanomedicine towards targeted cancer therapy.

Abstract

Developing agents that can accurately differentiate tumors from normal healthy tissues is of utmost importance for safe cancer therapy. Active targeting has been considered as an effective technique for tumor recognition. In this work, we demonstrate a folate-functionalized nanoscale covalent organic framework (FATD nCOF) highly specific to cancer cells through active targeting of their enriched folate receptors (FRs). The FATD nCOF prepared by simple post-synthetic modification of the COF surface defeats disperses well in water and exhibits a high loading capacity for various anticancer drugs. The biocompatible FATD nCOF is selectively internalized by FR-harboring cancer cells and consequently augments the efficacy of the loaded drug, Withaferin A (Wi-A), for targeted cancer cell killing. In biomolecular mechanism studies, Wi-A-loaded FATD (FATD@Wi-A) nanocomposites show remarkably a higher rate of apoptosis in FR-enriched cancer cells. Comparative analyses of FR-positive and FR-negative tumor xenografts reveal enhanced selective antitumor activity of FATD@Wi-A nanotherapeutics. Taken together, the study findings suggest that FATD nCOF holds great promise for active targeting of tumors in vivo. Our simple yet effective technology might be valuable for creating new state-of-the-art COFs for chemical and biomedical applications.

Keywords

covalent organic frameworkactive targetingfolate receptordrug deliverycancer therapy

Electronic Supplementary Material

Download File(s)
12274_2022_5265_MOESM1_ESM.pdf (2.8 MB)

References

[1]

Sawyers, C. Targeted cancer therapy. Nature 2004, 432, 294–297.
Crossref Google Scholar
[2]

Kowalski, P. S.; Bhattacharya, C.; Afewerki, S.; Langer, R. Smart Biomaterials: Recent advances and future directions. ACS Biomater. Sci. Eng. 2018, 4, 3809–3817.
Crossref Google Scholar
[3]

Lu, Y.; Aimetti, A. A.; Langer, R.; Gu, Z. Bioresponsive materials. Nat. Rev. Mater. 2017, 2, 16075–16092.
Crossref Google Scholar
[4]

Van Der Meel, R.; Sulheim, E.; Shi, Y.; Kiessling, F.; Mulder, W. J. M.; Lammers, T. Smart cancer nanomedicine. Nat. Nanotechnol. 2019, 14, 1007–1017.
Crossref Google Scholar
[5]

Srinivasarao, M.; Galliford, C. V.; Low, P. S. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat. Rev. Drug Discov. 2015, 14, 203–219.
Crossref Google Scholar
[6]

Yu, Y.; Yang, X.; Reghu, S.; Kaul, S. C.; Wadhwa, R.; Miyako, E. Photothermogenetic inhibition of cancer stemness by near-infrared-light-activatable nanocomplexes. Nat. Commun. 2020, 11, 4117.
Crossref Google Scholar
[7]

Xue, X. D.; Huang, Y. E.; Bo, R. N.; Jia, B.; Wu, H.; Yuan, Y.; Wang, Z. L.; Ma, Z.; Jing, D.; Xu, X. B. et al. Trojan horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat. Commun. 2018, 9, 3653.
Crossref Google Scholar
[8]

Bayón-Cordero, L.; Alkorta, I.; Arana, L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials (Basel) 2019, 9, 474.
Crossref Google Scholar
[9]

Liu, X. G.; Wu, M.; Wang, M.; Duan, Y. K.; Phan, C. U.; Chen, H.; Tang, G. P.; Liu, B. AIEgen-lipid conjugate for rapid labeling of neutrophils and monitoring of their behavior. Angew. Chem., Int. Ed. 2021, 60, 3175–3181.
Crossref Google Scholar
[10]

Yu, Y.; Yang, X.; Liu, M.; Nishikawa, M.; Tei, T.; Miyako, E. Amphipathic nanodiamond supraparticles for anticancer drug loading and delivery. ACS Appl. Mater. Interfaces 2019, 11, 18978–18987.
Crossref Google Scholar
[11]

Reina, G.; Zhao, L.; Bianco, A.; Komatsu, N. Chemical functionalization of nanodiamonds: Opportunities and challenges ahead. Angew. Chem., Int. Ed. 2019, 58, 17918–17929.
Crossref Google Scholar
[12]

Ambrogio, M. W.; Thomas, C. R.; Zhao, Y. L.; Zink, J. I.; Stoddart, J. F. Mechanized silica nanoparticles: A new frontier in theranostic nanomedicine. Acc. Chem. Res. 2011, 44, 903–913.
Crossref Google Scholar
[13]

Zhang, Z. J.; Wang, L. M.; Wang, J.; Jiang, X. M.; Li, X. H.; Hu, Z. J.; Ji, Y. L.; Wu, X. C.; Chen, C. Y. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv. Mater. 2012, 24, 1418–1423.
Crossref Google Scholar
[14]

Gong, F.; Cheng, L.; Yang, N. L.; Gong, Y. H.; Ni, Y. W.; Bai, S.; Wang, X. W.; Chen, M. C.; Chen, Q.; Liu, Z. Preparation of TiH1.924 nanodots by liquid-phase exfoliation for enhanced sonodynamic cancer therapy. Nat. Commun. 2020, 11, 3712.
Crossref Google Scholar
[15]

Pearce, A. K.; O’Reilly, R. K. Insights into active targeting of nanoparticles in drug delivery: Advances in clinical studies and design considerations for cancer nanomedicine. Bioconjugate Chem. 2019, 30, 2300–2311.
Crossref Google Scholar
[16]

Bhunia, S.; Deo, K. A.; Gaharwar, A. K. 2D covalent organic frameworks for biomedical applications. Adv. Funct. Mater. 2020, 30, 2002046.
Crossref Google Scholar
[17]

Zhang, L.; Wang, S. B.; Zhou, Y.; Wang, C.; Zhang, X. Z.; Deng, H. X. Covalent organic frameworks as favorable constructs for photodynamic therapy. Angew. Chem., Int. Ed. 2019, 58, 14213–14218.
Crossref Google Scholar
[18]

Peng, Y. W.; Huang, Y.; Zhu, Y. H.; Chen, B.; Wang, L. Y.; Lai, Z. C.; Zhang, Z. C.; Zhao, M. T.; Tan, C. L.; Yang, N. L. et al. Ultrathin two-dimensional covalent organic framework nanosheets: Preparation and application in highly sensitive and selective DNA detection. J. Am. Chem. Soc. 2017, 139, 8698–8704.
Crossref Google Scholar
[19]

Yu, F.; Liu, W. B.; Ke, S. W.; Kurmoo, M.; Zuo, J. L.; Zhang, Q. C. Electrochromic two-dimensional covalent organic framework with a reversible dark-to-transparent switch. Nat. Commun. 2020, 11, 5534.
Crossref Google Scholar
[20]

Geng, K. Y.; He, T.; Liu, R. Y.; Dalapati, S.; Tan, K. T.; Li, Z. P.; Tao, S. S.; Gong, Y. F.; Jiang, Q. H.; Jiang, D. L. Covalent organic frameworks: Design, synthesis, and functions. Chem. Rev. 2020, 120, 8814–8933.
Crossref Google Scholar
[21]

Segura, J. L.; Mancheño, M. J.; Zamora, F. Covalent organic frameworks based on schiff-base chemistry: Synthesis, properties and potential applications. Chem. Soc. Rev. 2016, 45, 5635–5671.
Crossref Google Scholar
[22]

She, P. F.; Qin, Y. Y.; Wang, X.; Zhang, Q. C. Recent progress in external-stimulus-responsive 2D covalent organic frameworks. Adv. Mater. 2022, 34, 2101175.
Crossref Google Scholar
[23]

Guan, Q.; Zhou, L. L.; Li, W. Y.; Li, Y. A.; Dong, Y. B. Covalent organic frameworks (COFs) for cancer therapeutics. Chem.—Eur. J. 2020, 26, 5583–5591.
Crossref Google Scholar
[24]

Zhang, L.; Yang, Q. C.; Wang, S.; Xiao, Y.; Wan, S. C.; Deng, H. X.; Sun, Z. J. Engineering multienzyme-mimicking covalent organic frameworks as pyroptosis inducers for boosting antitumor immunity. Adv. Mater. 2022, 34, 2108174.
Crossref Google Scholar
[25]

Feng, L. L.; Qian, C.; Zhao, Y. L. Recent advances in covalent organic framework-based nanosystems for bioimaging and therapeutic applications. ACS Mater. Lett. 2020, 2, 1074–1092.
Crossref Google Scholar
[26]

Li, Z. X.; Guo, J.; Wan, Y.; Qin, Y. T.; Zhao, M. T. Combining metal-organic frameworks (MOFs) and covalent-organic frameworks (COFs): Emerging opportunities for new materials and applications. Nano Res. 2022, 15, 3514–3532.
Crossref Google Scholar
[27]

Gao, P.; Wei, R. Y.; Cui, B. J.; Liu, X. H.; Chen, Y. Y.; Pan, W.; Li, N.; Tang, B. Ultrathin functionalized covalent organic framework nanosheets for tumor-targeted photodynamic therapy. Chem. Commun. 2021, 57, 6082–6085.
Crossref Google Scholar
[28]

Segura, J. L.; Royuela, S.; Ramos, M. M. Post-synthetic modification of covalent organic frameworks. Chem. Soc. Rev. 2019, 48, 3903–3945.
Crossref Google Scholar
[29]

Singh, N.; Kim, J.; Kim, J.; Lee, K.; Zunbul, Z.; Lee, I.; Kim, E.; Chi, S. G.; Kim, J. S. Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications. Bioact. Mater. 2023, 21, 358–380.
Crossref Google Scholar
[30]

Chen, L.; Wang, W. X.; Tian, J.; Bu, F. X.; Zhao, T. C.; Liu, M. C.; Lin, R. F.; Zhang, F.; Lee, M.; Zhao, D. Y. et al. Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy. Nat. Commun. 2021, 12, 4556.
Crossref Google Scholar
[31]

Diwakara, S. D.; Ong, W. S. Y.; Wijesundara, Y. H.; Gearhart, R. L.; Herbert, F. C.; Fisher, S. G.; McCandless, G. T.; Alahakoon, S. B.; Gassensmith, J. J.; Dodani, S. C. et al. Supramolecular reinforcement of a large-pore 2D covalent organic framework. J. Am. Chem. Soc. 2022, 144, 2468–2473.
Crossref Google Scholar
[32]

Li, Z. E.; He, T.; Gong, Y. F.; Jiang, D. L. Covalent organic frameworks: Pore design and interface engineering. Acc. Chem. Res. 2020, 53, 1672–1685.
Crossref Google Scholar
[33]

Mu, Z. J.; Zhu, Y. H.; Li, B. X.; Dong, A. W.; Wang, B.; Feng, X. Covalent organic frameworks with record pore apertures. J. Am. Chem. Soc. 2022, 144, 5145–5154.
Crossref Google Scholar
[34]

Vardhan, H.; Nafady, A.; Al-Enizi, A. M.; Ma, S. Q. Pore surface engineering of covalent organic frameworks: Structural diversity and applications. Nanoscale 2019, 11, 21679–21708.
Crossref Google Scholar
[35]

Sajid, M. Toxicity of nanoscale metal organic frameworks: A perspective. Environ. Sci. Pollut. Res. 2016, 23, 14805–14807.
Crossref Google Scholar
[36]

Zhao, F. L.; Liu, H. M.; Mathe, S. D. R.; Dong, A. J.; Zhang, J. H. Covalent organic frameworks: From materials design to biomedical application. Nanomaterials (Basel) 2018, 8, 15.
Crossref Google Scholar
[37]

Vyas, V. S.; Vishwakarma, M.; Moudrakovski, I.; Haase, F.; Savasci, G.; Ochsenfeld, C.; Spatz, J. P.; Lotsch, B. V. Exploiting noncovalent interactions in an imine-based covalent organic framework for quercetin delivery. Adv. Mater. 2016, 28, 8749–8754.
Crossref Google Scholar
[38]

Liu, C. H.; Zhang, W.; Zeng, Q. D.; Lei, S. B. A photoresponsive surface covalent organic framework: Surface-confined synthesis, isomerization, and controlled guest capture and release. Chem.—Eur. J. 2016, 22, 6768–6773.
Crossref Google Scholar
[39]

Zhang, G. Y.; Li, X. L.; Liao, Q. B.; Liu, Y. F.; Xi, K.; Huang, W. Y.; Jia, X. D. Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery. Nat. Commun. 2018, 9, 2785.
Crossref Google Scholar
[40]

Bertrand, N.; Wu, J.; Xu, X. Y.; Kamaly, N.; Farokhzad, O. C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014, 66, 2–25.
Crossref Google Scholar
[41]

Attia, M. F.; Anton, N.; Wallyn, N. J.; Omran, Z.; Vandamme, T. F. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J. Pharm. Pharmacol. 2019, 71, 1185–1198.
Crossref Google Scholar
[42]

Mitra, S.; Sasmal, H. S.; Kundu, T.; Kandambeth, S.; Illath, K.; Díaz, D. D.; Banerjee, R. Targeted drug delivery in covalent organic nanosheets (CONs) via sequential postsynthetic modification. J. Am. Chem. Soc. 2017, 139, 4513–4520.
Crossref Google Scholar
[43]

Zhi, Y. F.; Shao, P. P.; Feng, X.; Xia, H.; Zhang, Y. M.; Shi, Z.; Mu, Y.; Liu, X. M. Covalent organic frameworks: Efficient, metal-free, heterogeneous organocatalysts for chemical fixation of CO2 under mild conditions. J. Mater. Chem. A 2018, 6, 374–382.
Crossref Google Scholar
[44]

Xu, Q.; Tang, Y. P.; Zhang, X. B.; Oshima, Y.; Chen, Q. H.; Jiang, D. L. Template conversion of covalent organic frameworks into 2D conducting nanocarbons for catalyzing oxygen reduction reaction. Adv. Mater. 2018, 30, 1706330.
Crossref Google Scholar
[45]

Fernández, M.; Javaid, F.; Chudasama. V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem. Sci. 2018, 9, 790–810.
Crossref Google Scholar
[46]

Van Dam, G. M.; Themelis, G.; Crane, L. M. A.; Harlaar, N. J.; Pleijhuis, R. G.; Kelder, W.; Sarantopoulos, A.; De Jong, J. S.; Arts, H. J. G.; Van Der Zee, A. G. J. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results. Nat. Med. 2011, 17, 1315–1319.
Crossref Google Scholar
[47]

Yu, Y.; Wang, J.; Kaul, S. C.; Wadhwa, R.; Miyako, E. Folic acid receptor-mediated targeting enhances the cytotoxicity, efficacy, and selectivity of Withania somnifera leaf extract: In vitro and in vivo evidence. Front. Oncol. 2019, 9, 602.
Crossref Google Scholar
[48]

Zwicke, G. L.; Mansoori, G. A.; Jeffery, C. J. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev. 2012, 3, 18496.
Crossref Google Scholar
[49]

Sudimack, J.; Lee, R. J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 2000, 41, 147–162.
Crossref Google Scholar
[50]

Marchetti, C.; Palaia, I.; Giorgini, M.; De Medici, C.; Iadarola, R.; Vertechy, L.; Domenici, L.; Di Donato, V.; Tomao, F.; Muzii, L. et al. Targeted drug delivery via folate receptors in recurrent ovarian cancer: A review. OncoTargets Ther. 2014, 7, 1223–1236.
Crossref Google Scholar
[51]

Blanco, E.; Shen, H. F.; Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015, 33, 941–951.
Crossref Google Scholar
[52]

Vácha, R.; Martinez-Veracoechea, F. J.; Frenkel, D. Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett. 2011, 11, 5391–5395.
Crossref Google Scholar
[53]

Goldenthal, K. L.; Pastan, I.; Willingham, M. C. Initial steps in receptor-mediated endocytosis: The influence of temperature on the shape and distribution of plasma membrane clathrin-coated pits in cultured mammalian cells. Exp. Cell Res. 1984, 152, 558–564.
Crossref Google Scholar
[54]

Qin, S. Y.; Zhang, A. Q.; Cheng, S. X.; Rong, L.; Zhang, X. Z. Drug self-delivery systems for cancer therapy. Biomaterials 2017, 112, 234–247.
Crossref Google Scholar
Nano Research
Volume 16 Issue 5,
May 2023
Pages 7085-7094
DOI: 10.1007/s12274-022-5265-7
Cite this article:
Yu Y, Zhang G, Li Z, et al. Designed fabrication of active tumor targeting covalent organic framework nanotherapeutics via a simple post-synthetic strategy. Nano Research, 2023, 16(5): 7085-7094. https://doi.org/10.1007/s12274-022-5265-7
Topics:
Nano biology

1118

Views

7

Crossref

6

Web of Science

6

Scopus

0

CSCD

Altmetrics
Received: 30 June 2022
Revised: 28 October 2022
Accepted: 31 October 2022
Published: 03 January 2023
© Tsinghua University Press 2022
Return